User fee pilot strategy?
This article was originally published in The Gray Sheet
Executive Summary
Incremental adoption of device user fees would be preferable if the proposal is to be implemented at all, Council of Economic Advisors' Mark McClellan asserts at April 30 Capitol Hill cardiovascular disease event. "I think the Administration would like to see an effective mechanism put in place to help make sure that good devices get to the market as quickly as possible," he said. However, "if we're going to go down that road, it's best to start small and kind of gradually increase [the number of devices] if effective ways to do device user fees can be implemented." McClellan indicated that White House-level discussions about user fees have already taken place. Also at the April 30 event, Sen. Edward Kennedy (D-Mass.) told attendees, "I am strongly committed to...[working] with you to try and make sure...that the government is not going to [hinder your] extraordinary work"...
You may also be interested in...
FDA Commissioner Pool: McClellan Fits Non-Industry Profile; Is That Enough?
White House economic advisor Mark McClellan's viability as the next FDA commissioner hinges on Senate HELP Committee Chairman Edward Kennedy's (D-Mass.) willingness to look beyond the physician's strong ties to the Bush administration
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.